Sema4 (GeneDx parent)
Overview
Sema4 is a patient-centered health intelligence company that uses genomic and multiomic data analysis to enable more accurate diagnoses and advance precision medicine across rare disease and oncology.
Latest industry news
Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation
2026-10-12 · Industry
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion
2026-10-11 · Industry
NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?
2026-10-10 · Product
Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns
2026-10-09 · Research
Company details
Category
🧬 Clinical Diagnostics | Oncology Genomics | Pharmacogenomics
Location
Stamford, CT, USA
Funding
$220M Series B
Website
www.sema4.comListed
2026-06-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →